Inection Point Acquisition Corp (IPXGU) Stock Price & Analysis

Inection Point Acquisition Corp (IPXGU) closed at USD 10.95 on Wednesday, October 14, 2026, up 0.00% on the day. The US market is currently closed; this is not a live price.

The prior close was USD 10.95; the Oct 14, 2026 session ranged USD 0–0 on volume of 0 shares. Market capitalization is —, with a 52-week range of USD 0–11.1 (NGM). Source: Nexqual, retrieved October 16, 2026 at 07:25 UTC.

Also available as compact Markdown for AI agents: nexqual.com/IPXGU.md

Key facts (IPXGU)

Analysts (IPXGU)

Consensus None.

Total return (dividends reinvested) (IPXGU)

1Y (from 2026-02-11)5Y (from 2026-02-09)
Total return+9.4%+9.5%
S&P 500 (SPY)+18.1%+85.1%
Per year——
Volatility (annualized)8.0%6.5%
Max drawdown-2.5% (Jun 2026→Jun 2026)-1.1% (Apr 2026→May 2026)

Key Statistics (as of October 16, 2026 at 07:25 UTC)

PriceUSD 10.95
Change▲ 0.00% (up)
Previous CloseUSD 10.95
OpenUSD 0
Day RangeUSD 0 – 0
52-Week RangeUSD 0 – 11.1
Volume0 shares
Market Cap—
ExchangeNGM

Technical Analysis (IPXGU)

Nexqual's technical model rates IPXGU "NEUTRAL" based on 4 bullish and 3 bearish signals across 127 daily candles, as of October 16, 2026 at 07:25 UTC.

Overall SignalNEUTRAL
RSI (14)100 (overbought)
vs SMA50Below (USD 10.95)
MACD0 (positive)

Analyst Ratings (IPXGU)

Wall Street analysts rate IPXGU "None", per Nexqual as of October 16, 2026 at 07:25 UTC.

Consensus RatingNone

Earnings (IPXGU)

Source: Nexqual, October 16, 2026 at 07:25 UTC.

Financials & Fundamentals (IPXGU)

Gross Margin+0.00%
Operating Margin+0.00%
Profit Margin+0.00%
Current Ratio0.79
Total Cash$1.09M
Total Debt$0

Source: Nexqual, October 16, 2026 at 07:25 UTC.

Financial Health Score (IPXGU)

Nexqual rates Inection Point Acquisition Corp's overall financial health "Mixed" across five dimensions, as of October 16, 2026 at 07:25 UTC.

GrowthMixed — No data
ProfitabilityWeak — Gross margin 0%, operating 0%
Balance SheetMixed — $1M cash, no debt
Cash FlowMixed — No data
EfficiencyMixed — No data

Ownership (IPXGU)

Insider Ownership+1.12%
Institutional Ownership+4.59%
Float19.73M

Source: Nexqual, October 16, 2026 at 07:25 UTC.

Leadership (IPXGU)

Inection Point Acquisition Corp is led by Kevin George Shannon (age 29), Chief Executive Officer, per Nexqual as of October 16, 2026 at 07:25 UTC.

Chief Executive OfficerKevin George Shannon (age 29)
Chief Financial OfficerJoseph William Pooler (age 60)

Major Backers & Investors (IPXGU)

Notable institutional backers of Inection Point Acquisition Corp include OMERS Administration Corporation, Wealthspring Capital LLC, Westchester Capital Management, LLC, according to Nexqual as of October 16, 2026 at 07:25 UTC.

Active Investors

InvestorStake
OMERS Administration Corporation1.94%
Wealthspring Capital LLC0.87%
Westchester Capital Management, LLC0.73%
Merger Fund-The Merger Fund0.6%
Calamos Advisors LLC0.36%
HRT Financial LP0.36%
CALAMOS INVESTMENT TRUST/IL-Calamos Market Neutral Income Fund0.36%
Clear Street Group Inc.0.32%

Source: Nexqual, October 16, 2026 at 07:25 UTC.

Peers & Related Stocks

SymbolNamePriceChange
VYLRVylor Inc.USD 73.34▼ 4.68%
DMIIDrugs Made In America AcquisitiUSD 10.19▲ 0%
CCXIChurchill Capital Corp XIUSD 11.35▲ 1.7%
EVACEQV Ventures Acquisition Corp. USD 10.3▼ 0.1%
BCSSBain Capital GSS Investment CorUSD 10.22▼ 0.15%
CEPFCantor Equity Partners IV, Inc.USD 10.26▼ 0.24%

Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 16, 2026 at 07:25 UTC. This page is informational and not investment advice.

For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt